336 related articles for article (PubMed ID: 32449548)
1. Aromatase inhibitors: Role in postmenopausal breast cancer.
Kharb R; Haider K; Neha K; Yar MS
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000081. PubMed ID: 32449548
[TBL] [Abstract][Full Text] [Related]
2. Risks and benefits of aromatase inhibitors in postmenopausal breast cancer.
Michaud LB; Buzdar AU
Drug Saf; 1999 Oct; 21(4):297-309. PubMed ID: 10514021
[TBL] [Abstract][Full Text] [Related]
3. Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch.
Ratre P; Mishra K; Dubey A; Vyas A; Jain A; Thareja S
Anticancer Agents Med Chem; 2020; 20(17):1994-2004. PubMed ID: 32593281
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
Ahmad I; Shagufta
Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
[TBL] [Abstract][Full Text] [Related]
5. Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women.
Avvaru SP; Noolvi MN; Aminbhavi TM; Chkraborty S; Dash A; Shukla SS
Mini Rev Med Chem; 2018; 18(7):609-621. PubMed ID: 29090666
[TBL] [Abstract][Full Text] [Related]
6. Aromatase inhibitors in the treatment of breast cancer.
Brueggemeier RW; Hackett JC; Diaz-Cruz ES
Endocr Rev; 2005 May; 26(3):331-45. PubMed ID: 15814851
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer.
Lønning PE
Breast Cancer Res Treat; 1998; 49 Suppl 1():S45-52; discussion S73-7. PubMed ID: 9797017
[TBL] [Abstract][Full Text] [Related]
8. New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women.
de Jong PC; Blijham GH
Neth J Med; 1999 Aug; 55(2):50-8. PubMed ID: 10474272
[TBL] [Abstract][Full Text] [Related]
9. Aromatase inhibitors in the treatment of postmenopausal breast cancer.
Bajetta E; Zilembo N; Bichisao E
Drugs Aging; 1999 Oct; 15(4):271-83. PubMed ID: 10582774
[TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibitors for breast cancer in postmenopausal women.
Campos SM
Oncologist; 2004; 9(2):126-36. PubMed ID: 15047917
[TBL] [Abstract][Full Text] [Related]
11. Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer.
Bertelli G; Garrone O; Merlano M; Occelli M; Bertolotti L; Castiglione F; Pepi F; Fusco O; Del Mastro L; Leonard RC
Oncology; 2005; 69(6):471-7. PubMed ID: 16410685
[TBL] [Abstract][Full Text] [Related]
12. The evolving role of aromatase inhibitors in breast cancer.
Mokbel K
Int J Clin Oncol; 2002 Oct; 7(5):279-83. PubMed ID: 12402060
[TBL] [Abstract][Full Text] [Related]
13. Are differences in the available aromatase inhibitors and inactivators significant?
Johnson PE; Buzdar A
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4360s-4368s; discussion 4411s-4412s. PubMed ID: 11916226
[TBL] [Abstract][Full Text] [Related]
14. Biology of aromatase inhibitors: pharmacology/endocrinology within the breast.
Miller WR
Endocr Relat Cancer; 1999 Jun; 6(2):187-95. PubMed ID: 10731108
[TBL] [Abstract][Full Text] [Related]
15. Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer.
Tominaga T; Adachi I; Sasaki Y; Tabei T; Ikeda T; Takatsuka Y; Toi M; Suwa T; Ohashi Y
Ann Oncol; 2003 Jan; 14(1):62-70. PubMed ID: 12488294
[TBL] [Abstract][Full Text] [Related]
16. Role of anti-aromatase agents in postmenopausal advanced breast cancer.
Murray R
Cancer Chemother Pharmacol; 2001 Oct; 48(4):259-65. PubMed ID: 11710624
[TBL] [Abstract][Full Text] [Related]
17. Anti-aromatase agents in the treatment and prevention of breast cancer.
Goss P
Cancer Control; 2002; 9(2 Suppl):2-8. PubMed ID: 11965225
[TBL] [Abstract][Full Text] [Related]
18. Novel non-steroidal aromatase inhibitors: are there new perspectives in the treatment of breast cancer?
Bajetta E; Celio L; Buzzoni R; Bichisao E
Tumori; 1996; 82(5):417-22. PubMed ID: 9063515
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors in breast cancer.
Brodie A
Trends Endocrinol Metab; 2002 Mar; 13(2):61-5. PubMed ID: 11854020
[TBL] [Abstract][Full Text] [Related]
20. Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer.
Jiao J; Xiang H; Liao Q
Curr Med Chem; 2010; 17(30):3476-87. PubMed ID: 20738251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]